Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06890260Recruiting
Randomised, open-label trial (2 arms). Primary endpoint: Total Nasal Symptom Score. Started Apr 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06890260.